CLINICAL_TRIALS
trial_result
· 2019-09-16
Clinical Trial Update: Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients [Phase 2]
Summary
A Phase 2 extension study update for BPS-MR-PAH-203 in patients with pulmonary arterial hypertension (PAH).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lung Biotechnology PBC | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-09-16